e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Clinical challenges in respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence and risk factors of frailty in patients with mycobacterium avium complex lung disease-preliminary study-
K. Fujita (Kyoto, Japan), Y. Ito (Nagoya, Japan), N. Uchida (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan)
Source:
International Congress 2018 – Clinical challenges in respiratory infection
Session:
Clinical challenges in respiratory infection
Session type:
Thematic Poster
Number:
4701
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Fujita (Kyoto, Japan), Y. Ito (Nagoya, Japan), N. Uchida (Kyoto, Japan), O. Kanai (Kyoto, Japan), M. Okamura (Kyoto, Japan), K. Nakatani (Kyoto, Japan), T. Mio (Kyoto, Japan). Prevalence and risk factors of frailty in patients with mycobacterium avium complex lung disease-preliminary study-. 4701
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey
Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017
Year: 2018
Factors related to response to intermittent treatment of
mycobacterium avium
complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006
Clinical characteristics and outcomes of patients with Mycobacterium avium complex lung disease positive for Aspergillus precipitating antibody
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Risk factors for extrapulmonar tuberculosis
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Assessment of risk factors for the formation of polyorgan tuberculosis in children infected with MBT
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
Clinical characteristics and treatment outcomes of patients with macrolide-resistant Mycobacterium avium complex pulmonary disease: a systemic review and meta-analysis
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Effect of the risk factors on the characteristics of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups
Year: 2008
Genome-wide association study in patients with pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019
Year: 2021
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
The impact of different antibiotic treatment regimens on mortality in
Mycobacterium avium
complex pulmonary disease: a population-based cohort study
Source: Eur Respir J, 56 (3) 1901875; 10.1183/13993003.01875-2019
Year: 2020
Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Risk factors associated with death in pulmonary tuberculosis
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Characteristics and outcomes of 197 patients newly diagnosed with pulmonary mycobacterium avium complex disease
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Characteristics and risk factors for missed pulmonary tuberculosis
Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations
Year: 2020
Risk factors of intrahospital mortality for pulmonary tuberculosis
Source: Annual Congress 2007 - Clinical epidemiology of tuberculosis
Year: 2007
HIV and multidrug-resistant tuberculosis: overlapping risk factors
Source: Eur Respir J 2015; 45: 567-569
Year: 2015
Risk factors for fatal tuberculosis among immunocompetent patients.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept